Portage Biotech Inc (PRTG) — Cash Flow-to-Debt Ratio
Portage Biotech Inc (PRTG) has a Cash Flow-to-Debt Ratio of -0.78x as of September 2024, meaning its operating cash flow of $-1.56 Million could theoretically repay -1% of its total liabilities ($2.01 Million) in one year. See PRTG free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Portage Biotech Inc Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Portage Biotech Inc across 27 annual periods. Also explore PRTG year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Portage Biotech Inc (1998–2025)
Year-by-year debt coverage analysis for Portage Biotech Inc. For market capitalisation and broader financial context, see Portage Biotech Inc (PRTG) total market value.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.79x | $-5.46 Million | $3.05 Million | ▲ +44.3% |
| 2024 | -3.21x | $-14.30 Million | $4.45 Million | ▼ -531.6% |
| 2023 | -0.51x | $-12.07 Million | $23.73 Million | ▼ -119.8% |
| 2022 | -0.23x | $-6.76 Million | $29.23 Million | ▼ -47.2% |
| 2021 | -0.16x | $-4.28 Million | $27.26 Million | ▼ -16.5% |
| 2020 | -0.13x | $-3.71 Million | $27.53 Million | ▼ -295.5% |
| 2019 | -0.03x | $-858.00K | $25.16 Million | ▲ +98.8% |
| 2018 | -2.79x | $-1.07 Million | $384.00K | ▲ +34.6% |
| 2017 | -4.27x | $-1.32 Million | $309.43K | ▲ +78.1% |
| 2016 | -19.48x | $-5.84 Million | $299.74K | ▼ -362.5% |
| 2015 | -4.21x | $-2.61 Million | $620.56K | ▲ +58.2% |
| 2014 | -10.08x | $-1.94 Million | $191.97K | ▼ -151.5% |
| 2013 | -4.01x | $-1.79 Million | $446.87K | ▼ -696.4% |
| 2012 | -0.50x | $-1.34 Million | $2.66 Million | ▲ +86.9% |
| 2011 | -3.84x | $-2.62 Million | $682.75K | ▼ -3626.2% |
| 2010 | -0.10x | $-356.14K | $3.45 Million | ▲ +95.7% |
| 2009 | -2.39x | $-287.38K | $120.39K | ▲ +70.8% |
| 2008 | -8.18x | $-468.92K | $57.34K | ▲ +25.1% |
| 2007 | -10.93x | $-458.84K | $42.00K | ▼ -139.5% |
| 2006 | -4.56x | $-645.50K | $141.52K | ▼ -837.2% |
| 2004 | -0.49x | $-321.51K | $660.63K | ▲ +22.5% |
| 2003 | -0.63x | $-146.90K | $233.80K | ▲ +49.3% |
| 2002 | -1.24x | $-156.80K | $126.48K | ▲ +66.2% |
| 2001 | -3.67x | $-347.00K | $94.62K | ▼ -19.1% |
| 2000 | -3.08x | $-466.90K | $151.67K | ▲ +41.9% |
| 1999 | -5.30x | $-345.09K | $65.14K | ▼ -522.1% |
| 1998 | -0.85x | $-422.97K | $496.67K | — |